Fig. 3.
![Fig. 3. Defensin isolate as competitor for the HLA-DR1 binder AMCA-HA 306-18. / Competition kinetics of defensins (10 μg [○]; 20 μg [×]) and different HLA-DR1-binding peptides (CLIP 80-104: LPKPPKPVSKMRMATPLLMQALPMG (□); IM 19-31: PLKAEIAQRLEDV (▪), and HA 306-18 (PKYVKQNTLKLAT ([▴]), each of them at a concentration of 30 μmol/L) to solubilized HLA-DR using a gel filtration assay; 1.5 μmol/L of AMCA-labeled HA 306-18 was used as a binding peptide.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/95/9/10.1182_blood.v95.9.2890.009k09_2890_2896/5/bloo00909003x.jpeg?Expires=1735837576&Signature=PxxAzP9qhBjIpvieNB47fWSkEXs5NHPsFzQV7B~KWot~OjfEezB2sxwWtuIxbfmT4Gs6WhL0CH3xd-0kXAjz3vmaz-QoY~7i4i5N9uCGS2M8dej9idqr6LjcBuCyPLfOGWSVoYOsN~7P~GM-UYOt4gZVEp2kKRVwJ56xvHk71gHKNlDQP7J2PonlPIqqAYW3xWPcRYBk7jyc64stfEekKAmJTlcqQRwOe8-bdbCoAmFhqA9sjEY1~fi587vkYZcxRtuChAZNv9g8pKhYNuIFVBHTbxe8g3Xy3uvvTMauk~Z9oX3HfZ14aLp5CXolD0p8Ejsfv8rMAZSw4aSgC4zWDw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Defensin isolate as competitor for the HLA-DR1 binder AMCA-HA 306-18.
Competition kinetics of defensins (10 μg [○]; 20 μg [×]) and different HLA-DR1-binding peptides (CLIP 80-104: LPKPPKPVSKMRMATPLLMQALPMG (□); IM 19-31: PLKAEIAQRLEDV (▪), and HA 306-18 (PKYVKQNTLKLAT ([▴]), each of them at a concentration of 30 μmol/L) to solubilized HLA-DR using a gel filtration assay; 1.5 μmol/L of AMCA-labeled HA 306-18 was used as a binding peptide.
